Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

New Therapies in AML: Is It Safe to Wait for Genomic Info to Start Therapy? How To Tailor the Therapy? Data on Targeting BCL-2 with Venetoclax

367 views
March 9, 2020
Comments 0
Login to view comments. Click here to Login